Intraneuronal accumulation and persistence of radiolabel in rat brain following in vivo administration of [3H]‐chlorisondamine

British Journal of Pharmacology

Volumn 116, Issue 5, 1995, Pages 2503-2509

  El Bizri H ^a   Rigdon, M G ^a,b   Clarke, P B S ^a  

^a MCGILL UNIVERSITY   (Canada)

^b DUPONT COMPANY   (United States)

Author keywords

autoradiography; Chlorisondamine; dopamine; nicotine; retrograde transport; subcellular fractions; transmitter release; 3H chlorisondamine

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHLORISONDAMINE; DOPAMINE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CEREBELLUM; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DORSAL RAPHE NUCLEUS; DRUG ACCUMULATION; HIPPOCAMPUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MESENCEPHALON; NEUROANATOMY; NONHUMAN; PRIORITY JOURNAL; RAT; RETROGRADE NERVE FIBER TRANSPORT; SEROTONINERGIC NERVE CELL; SUBSTANTIA NIGRA; SYNAPTOSOME; TISSUE DISTRIBUTION; VENTRAL TEGMENTUM;

ANIMAL; AUTORADIOGRAPHY; AXONAL TRANSPORT; BRAIN; CHLORISONDAMINE; DOPAMINE; IN VITRO; INJECTIONS, INTRAVENTRICULAR; MALE; NEURONS; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; SUBCELLULAR FRACTIONS; SUPPORT, NON-U.S. GOV'T; SYNAPTOSOMES;

EID: 0028785021     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1995.tb15102.x     Document Type: Article

References (54)

1. Effect of preganglionic nerve stimulation on sensitivity of the superior cervical ganglion to nicotinic blocking agents
2. Neuro‐transmission regulates stability of acetylcholine receptors at the neuromuscular junction
3. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein‐dye binding
4. + in the rat
5. Chronic central nicotinic blockade after a single administration of the bisquaternary ganglion‐blocking drug chlorisondamine
6. Autoradiographic distribution of nicotine receptors in rat brain
7. The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion
8. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats
9. Characterization of the locomotor stimulant action of nicotine in tolerant rats
10. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
11. Decamethonium in depolarized muscle and the effects of tubocurarine
12. Entry of decamethonium in rat muscle studied by autoradiography. J
13. A method for the demonstration of monoamine‐containing nerve fibers in the central nervous system
14. Effects of chlorisondamine on nicotinic receptor binding in whole brain and nicotine‐induced changes in locomotor activity in rats
15. Neostriatal projections from individual cortical fields conform to histochemically distinct striatal compartments in the rat
16. Regulation of nicotinic receptors in rat brain following quasi‐irreversible nicotinic blockade by chlorisondamine and chronic treatment with nicotine
17. Blockade of nicotinic receptor‐mediated release of dopamine from striatal synaptosomes by chlorisondamine administered in vivo
18. Blockade of nicotinic receptor‐mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro
19. Evidence for a crossed nigrostriatal pathway in rats
20. Conditioned aversion after delay place conditioning with nicotine
21. Regulation of turnover and number of acetylcholine receptors at neuromuscular junctions
22. The neostriatal mosaic: Compartmentalization of corticostriatal input and striatonigral output systems
23. The neostriatal mosaic: II patch‐and matrix‐direted neostriatal dopaminergic and non‐dopaminergic systems
24. Crossed connections of the substantia nigra in the rat
25. A new orally active quaternary ammonium, ganglion blocking drug capable of reducing blood pressure, SU‐3088
26. 3H]cytisine
27. + within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study
28. Metabolic stability and antigenic modulation of nicotinic acetylcholine receptors on bovine adrenal chromaffin cells
29. Some observations on the binding patterns of alpha‐bungarotoxin in the central nervous system of the rat
30. Cholinergic function and alpha‐bungarotoxin binding in PC12 cells
31. Nicotine cue in rats: effects of central administration of ganglion‐blocking drugs
32. Different types of blockade of crustacean acetylcholine‐induced currents
33. Blockade of cholinergic channels by chlorisondamine on a crustacean muscle
34. Autoradiographic localization of [3H]nicotine binding sites in the rat brain
35. Barrel rotation and prostration by vasopressin and nicotine in the vestibular cerebellum
36. Absorption, distribution, fate and excretion of ganglion‐blocking drugs
37. Central catecholamine neuron systems: anatomy and physiology of the dopamine systems
38. Actions of nicotine on the acquisition of an autoshaped lever‐touch response in rats
39. Trapping of an open‐channel blocker at the frog neuromuscular acetylcholine channel
40. Nicotine‐induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover
41. Ganglionic blockade by a new bisquaternary series, including chlorisondamine dimethochloride
42. Stereoselective nicotine‐induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation
43. Chlorisondamine blocks acquisition of the conditioned taste aversion produced by (−)−nicotine
44. Immunocytochemical localization of glutamate decarboxylase in rat substantia nigra
45. GABAergic nerve terminals decrease in the substantia nigra following hemitransections of the striato nigral and pallido nigral pathways
46. Rapid efflux of some quaternary compounds from cerebrospinal fluid
47. Electrophysiological investigation of chlorisondamine dimethochloride (EcolidTM). A new ganglionic blocking agent
48. 125I‐neuronal bungarotoxin. J
49. Serotonergic and non‐serotonergic projections from the nucleus raphe dorsalis to the caudate‐putamen complex in the rat, studied by a combined immuno‐fluorescence and fluorescent retrograde axonal labeling technique
50. Regarding a necessary condition for ganglionic blockade with competitive agents
51. Differential serotonergic innervation of individual hypothalamic nuclei and other forebrain regions by the dorsal and median midbrain raphe nuclei
52. Single subthalamic nucleus neurons project to both the globus pallidus and substantia nigra in rat
53. Tritium labeling by exposure of organic compounds to tritium gas